APLM Apollomics highlights oncology pipeline progress and upcoming clinical trial milestones in its latest quarterly earnings report UMBF UMB delivers 52 percent Q4 2025 EPS beat but shares drop 113 percent in todays trading VNCE Vince Holding posts 782 percent Q1 2026 EPS surprise far exceeding analyst consensus projections KIDZW Classover leadership outlines edtech growth priorities ahead of full quarterly earnings disclosures Capital One Financial COF Bank of America Reiterates Buy Rating 234 Price Target Amid Temporary Q1 Headwinds